Keywords: زیرکونیوم 89; Monte Carlo; Integral yield; Radionuclide; Zirconium-89;
مقالات ISI زیرکونیوم 89 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: زیرکونیوم 89; Zirconium-89; 89Zr; Zr-89; Ti-44; Spot welding; Cyclotron solid targetry;
Positron Emission Tomography/Computed Tomography with 89Zr-girentuximab Can Aid in Diagnostic Dilemmas of Clear Cell Renal Cell Carcinoma Suspicion
Keywords: زیرکونیوم 89; Girentuximab; Zirconium-89; Positron emission tomography/computed tomography imaging; Renal cell carcinoma;
Synthesis and evaluation of bifunctional tetrahydroxamate chelators for labeling antibodies with 89Zr for imaging with positron emission tomography
Keywords: زیرکونیوم 89; Zirconium-89; Tetrahydroxamate chelator; Monoclonal antibody; Molecular imaging; Positron emission tomography;
Hydroxamate column-based purification of zirconium-89 (89Zr) using an automated fluidic platform
Keywords: زیرکونیوم 89; Zirconium-89; 89Zr; ImmunoPET; Medical isotope; Laboratory automation; Hydroxamate; Deferoxamine;
Optimized anion exchange column isolation of zirconium-89 (89Zr) from yttrium cyclotron target: Method development and implementation on an automated fluidic platform
Keywords: زیرکونیوم 89; Zirconium-89; ImmunoPET; Medical isotope; Automation; Anion exchange; Fluoride complexation;
Evaluation of a chloride-based 89Zr isolation strategy using a tributyl phosphate (TBP)-functionalized extraction resin
Keywords: زیرکونیوم 89; immunoPET; Positron emission tomography; Zirconium-89; zr89;
89Zr for antibody labeling and in vivo studies - A comparison between liquid and solid target production
Keywords: زیرکونیوم 89; Zirconium-89; Liquid target; Radioimmunoimaging; Positron emission tomography;
Biodistribution and PET imaging of 89-zirconium labeled cerium oxide nanoparticles synthesized with several surface coatings
Keywords: زیرکونیوم 89; Cerium oxide nanoparticles; PET imaging; Biodistribution; Surface coating; Antioxidant; Zirconium-89; %ID/g; percent injected dose per gram; CONP; cerium oxide nanoparticle; DFO; desferoxamine; DLS; dynamic light scattering; DSS; dextran sodium sulfate; D
Production of Zr-89 using sputtered yttrium coin targets
Keywords: زیرکونیوم 89; Zirconium-89; Sputtered coins; Yttrium; Degrader; Zirconium-88; Isotope production;
Radiosynthesis and preclinical PET evaluation of 89Zr-nivolumab (BMS-936558) in healthy non-human primates
Keywords: زیرکونیوم 89; Nivolumab; Opdivo; PET; Zirconium-89; PD-1; PD-L1; BMS-936558;
Design, synthesis and evaluation of novel bifunctional tetrahydroxamate chelators for PET imaging of 89Zr-labeled antibodies
Keywords: زیرکونیوم 89; Zirconium-89; Bifunctional chelators; Antibody; Trastuzumab; Molecular imaging; Positron emission tomography;
HDL mimetic CER-001 targets atherosclerotic plaques in patients
Keywords: زیرکونیوم 89; Imaging; PET/CT; MRI; HDL mimetic; CER-001; Apolipoprotein A-I; Zirconium-89; Nanomedicine;
In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models
Keywords: زیرکونیوم 89; atherosclerosis; high-density lipoprotein; PET/CT; PET/MRI; zirconium-89
Associate editor: B. TeicherTargeting breast cancer through its microenvironment: Current status of preclinical and clinical research in finding relevant targets
Keywords: زیرکونیوم 89; Microenvironment; Breast cancer; Targeted therapy; Biomarkers; Metastasis; Metabolism; 18F; Fluor-18; 89Zr; zirconium-89; 111In; indium; CAF; cancer associated fibroblast; cMET; C-mesenchymal-epithelial transition factor; CSF; colony stimulating factor;
Visualising dual downregulation of insulin-like growth factor receptor-1 and vascular endothelial growth factor-A by heat shock protein 90 inhibition effect in triple negative breast cancer
Keywords: زیرکونیوم 89; IGF-1R; VEGF-A; Hsp90 inhibition; Triple negative breast cancer; Biomarker; Zirconium-89; PET;
Implementation of 89Zr production and in vivo imaging of B-cells in mice with 89Zr-labeled anti-B-cell antibodies by small animal PET/CT
Keywords: زیرکونیوم 89; Zirconium-89; Monoclonal antibody; Positron emission tomography; B220
89Zr-trastuzumab PET visualises HER2 downregulation by the HSP90 inhibitor NVP-AUY922 in a human tumour xenograft
Keywords: زیرکونیوم 89; HER2; Heat shock protein 90; NVP-AUY922; Zirconium-89; Positron emission tomography; Breast cancer; Biomarker
Site-specifically 89Zr-labeled monoclonal antibodies for ImmunoPET
Keywords: زیرکونیوم 89; ImmunoPET; Zirconium-89; Site-specifically labeled antibodies; Thiol specific desferrioxamine reagent; Iodoacetate; Bromoacetate; Maleimide; Imaging; Trastuzumab; PHESELECTOR; THIOMAB
Standardized methods for the production of high specific-activity zirconium-89
Keywords: زیرکونیوم 89; Zirconium-89; Cyclotron targetry; Hydroxamates; Desferrioxamine; Radiopharmaceuticals; Positron emission tomography